预测WIfI临床4期慢性肢体威胁性缺血患者血管内治疗后大截肢的评分模型
本研究为单中心回顾性观察研究,纳入2007年4月至2016年12月接受血管内治疗的WIfI临床4期慢性肢体威胁性缺血患者194条肢体,构建基于血液透析、fI3、足趾创面及创面可见血流的评分模型,该模型可将1年无大截肢率、创面愈合率及无截肢生存率分层。
要点
- 血液透析(HR 2.63)和fI3(HR 2.54)是大截肢的正向预测因子,各计1分。
- 足趾创面(HR 0.29)和创面可见血流(HR 0.43)是大截肢的负向预测因子,各减1分。
- 评分模型将1年无大截肢率分为低危96.6%、中危72.4%、高危67.3%(p<0.001)。
核心结论
- 基于大截肢预测因子构建的评分模型可对WIfI临床4期慢性肢体威胁性缺血患者的临床结局进行分层。
研究设计与样本
- 本研究为单中心回顾性观察研究,2007年4月至2016年12月共353例慢性肢体威胁性缺血患者(390条肢体)接受血管内治疗,排除WIfI临床1、2、3期后纳入194条WIfI临床4期肢体(49.7%)。
主要发现
- 1年大截肢发生率为18.0%(35条肢体)。
- Cox比例风险分析显示,血液透析(HR 2.63;95%CI 1.24-5.58;p=0.012)和fI3(HR 2.54;95%CI 1.28-5.06;p=0.008)与大截肢相关。
- 足趾创面(HR 0.29;95%CI 0.094-0.88;p=0.029)和创面可见血流(HR 0.43;95%CI 0.21-0.89;p=0.023)与大截肢相关。
- 1年无大截肢率低危组96.6%、中危组72.4%、高危组67.3%(p<0.001);创面愈合率低危组67.8%、中危组27.6%、高危组4.1%(p<0.001);无截肢生存率低危组65.3%、中危组44.8%、高危组18.4%(p<0.001)。
关键数值与推荐
- 血液透析和fI3各计1分,足趾创面和创面可见血流各减1分。
- 评分-2或-1定义为低危组,0定义为中危组,+1或+2定义为高危组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated the predictors of major amputation (MA) at 1 year and prepared a scoring model to stratify the clinical outcomes of chronic limb-threatening ischemia (CLTI) patients at wound, ischemia, and foot infection (WIfI) clinical stage 4 after endovascular therapy (EVT). MATERIALS AND METHODS: This study was a retrospective, observational study performed at a single center. A total of 353 CLTI patients (390 limbs) were treated with EVT between April 2007 and December 2016. Among these, limbs at WIfI clinical stages 1, 2, and 3 were excluded, and 194 limbs at WIfI clinical stage 4 (49.7%) were enrolled. The primary endpoint was major amputation (MA) free rate at 1 year. Predictors of MA at 1 year was evaluated by Cox proportional hazard analysis. RESULTS: At 1 year, the incidence of MA was 18.0% (35 limbs). Cox proportional hazard analysis revealed that hemodialysis (hazard ratio [HR] 2.63; 95% confidence interval [CI], 1.24-5.58; p=0.012), fI3 (HR 2.54; 95% CI, 1.28-5.06; p=0.008), toe wounds (HR 0.29; 95% CI, 0.094-0.88; p=0.029), and visible blood flow to the wound (HR 0.43; 95% CI, 0.21-0.89; p=0.023) were associated with MA. We assigned 1 point for positive predictors of MA, hemodialysis, and fI3; 1 point was deducted for negative predictors of MA, toe wounds, and visible blood flow to the wound. A score of -2 or -1, was defined as the low-risk group, 0 was defined as the intermediate-risk group, and +1 or +2 were defined as the high-risk group. At 1 year, MA free rate, wound healing rate, and amputation-free survival rate were stratified according to a scoring model. MA free rate was 96.6% in low-risk, 72.4% in intermediate-risk, and 67.3% in high-risk (p<0.001); wound healing rate was 67.8% in low-risk, 27.6% in intermediate-risk, and 4.1% in high-risk (p<0.001); amputation-free survival rate was 65.3% in low-risk, 44.8% in intermediate-risk, and 18.4% in high-risk (p<0.001). CONCLUSIONS: The scoring model based on the predictors of MA stratified clinical outcomes in CLTI patients at WIfI clinical stage 4.
引用
- Kobayashi N, Yamawaki M, Mori S, et al. Scoring Model to Predict Major Amputation in Patients With Chronic Limb-Threatening Ischemia at Wound, Ischemia, and Foot Infection Clinical Stage 4 After Endovascular Therapy. J Endovasc Ther. 2021. PMID: 34802303. doi:10.1177/15266028211059453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。